ABVC BIOPHARMA, INC. Operating Lease, Expense
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-08-12
- ABVC BIOPHARMA, INC. operating lease, expense for the quarter ending 2026-06-30 was $134.41K, a 14.72% increase year-over-year.
- ABVC BIOPHARMA, INC. operating lease, expense for the quarter ending 2026-03-31 was $145.13K, a 23.87% increase year-over-year.
- ABVC BIOPHARMA, INC. operating lease, expense for the quarter ending 2025-12-31 was $129.62K, a 58.88% decline year-over-year.
- ABVC BIOPHARMA, INC. operating lease, expense for the quarter ending 2025-09-30 was $120.17K, a 19.35% increase year-over-year.
- ABVC BIOPHARMA, INC. operating lease, expense for fiscal 2025 was $486.28K, a 5.47% decline from fiscal 2024.
- ABVC BIOPHARMA, INC. operating lease, expense for fiscal 2024 was $514.42K, a 43.46% increase from fiscal 2023.
- ABVC BIOPHARMA, INC. operating lease, expense for fiscal 2023 was $358.58K, a 0.00% change from fiscal 2022.
- ABVC BIOPHARMA, INC. operating lease, expense for fiscal 2022 was $358.58K, a 6.97% increase from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 3 month as first filed | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 9 month as first filed | Operating Lease, Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $134.41K 10-Q · filed 2026-08-12 | $279.54K 10-Q · filed 2026-08-12 | $409.16K derived: sum of 3 quarters · filed 2026-08-12 | $529.33K derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2026-03-31 | $145.13K 10-Q · filed 2026-05-18 | $274.75K derived: sum of 2 quarters · filed 2026-05-18 | $394.92K derived: sum of 3 quarters · filed 2026-05-18 | $512.09K derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-12-31 | $129.62K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | $249.78K derived: sum of 2 quarters · filed 2026-03-03 | $366.95K derived: sum of 3 quarters · filed 2026-08-12 | $486.28K 10-K · filed 2026-03-03 | ||
| 2025-09-30 | $120.17K 10-Q/A · filed 2026-03-03 | $237.33K derived: sum of 2 quarters · filed 2026-08-12 | $356.66K 10-Q/A · filed 2026-03-03 | $669.73K derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-06-30 | $117.17K 10-Q · filed 2026-08-12 | $236.50K 10-Q · filed 2026-08-12 | $549.57K derived: sum of 3 quarters · filed 2026-08-12 | $650.25K derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-03-31 | $117.17K 10-Q · filed 2026-05-18 | $432.40K derived: sum of 2 quarters · filed 2026-05-18 | $533.08K derived: sum of 3 quarters · filed 2026-05-18 | $633.77K derived: sum of 4 quarters · filed 2026-05-18 | ||
| 2024-12-31 | $315.23K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | $415.92K derived: sum of 2 quarters · filed 2026-03-03 | $516.60K derived: sum of 3 quarters · filed 2026-03-03 | $514.42K 10-K · filed 2026-03-03 | ||
| 2024-09-30 | $100.69K 10-Q/A · filed 2026-03-03 | $134.79K 10-Q · filed 2024-11-14 | $201.37K derived: sum of 2 quarters · filed 2026-03-03 | $199.19K 10-Q/A · filed 2026-03-03 | $397.26K 10-Q · filed 2024-11-14 | $369.70K derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | $100.69K 10-Q · filed 2025-08-13 | $199.19K 10-Q · filed 2025-08-13 | $269.01K derived: sum of 3 quarters · filed 2025-08-13 | $365.89K derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | $98.50K 10-Q · filed 2025-04-30 | $168.33K derived: sum of 2 quarters · filed 2025-04-30 | $265.20K derived: sum of 3 quarters · filed 2025-04-30 | $362.78K derived: sum of 4 quarters · filed 2025-04-30 | ||
| 2023-12-31 | $69.83K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $166.70K derived: sum of 2 quarters · filed 2025-04-15 | $264.28K derived: sum of 3 quarters · filed 2025-04-15 | $358.58K 10-K · filed 2025-04-15 | ||
| 2023-09-30 | $96.88K 10-Q · filed 2024-11-14 | $194.45K derived: sum of 2 quarters · filed 2024-11-14 | $288.75K 10-Q · filed 2024-11-14 | $385.83K derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $97.58K 10-Q · filed 2024-08-14 | $191.88K 10-Q · filed 2024-08-14 | $288.96K derived: sum of 3 quarters · filed 2024-08-14 | $376.32K derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $94.30K 10-Q · filed 2024-05-17 | $191.38K derived: sum of 2 quarters · filed 2024-05-17 | $278.75K derived: sum of 3 quarters · filed 2024-05-17 | $367.02K derived: sum of 4 quarters · filed 2024-05-17 | ||
| 2022-12-31 | $97.08K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $184.45K derived: sum of 2 quarters · filed 2024-03-13 | $272.72K derived: sum of 3 quarters · filed 2024-03-13 | $358.58K 10-K · filed 2024-03-13 | ||
| 2022-09-30 | $87.37K 10-Q · filed 2023-11-15 | $175.64K derived: sum of 2 quarters · filed 2023-11-15 | $261.49K 10-Q · filed 2023-11-15 | $431.57K derived: sum of 4 quarters · filed 2023-11-15 | ||
| 2022-06-30 | $88.27K 10-Q · filed 2023-08-14 | $174.13K 10-Q · filed 2023-08-14 | $344.21K derived: sum of 3 quarters · filed 2023-08-14 | $430.49K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $85.86K 10-Q · filed 2023-05-15 | $255.94K derived: sum of 2 quarters · filed 2023-05-15 | $342.22K derived: sum of 3 quarters · filed 2023-05-15 | $428.50K derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $170.08K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $256.36K derived: sum of 2 quarters · filed 2023-03-31 | $342.64K derived: sum of 3 quarters · filed 2023-03-31 | $335.21K 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $86.28K 10-Q · filed 2022-11-14 | $172.56K derived: sum of 2 quarters · filed 2022-11-14 | $165.13K 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $86.28K 10-Q · filed 2022-08-15 | $165.13K 10-Q · filed 2022-08-15 |